Postnatal methylazoxymethanol: sensitive periods and regional selectivity of effects.

Work on neonatal MAM exposure has focused primarily on exposure within the first week postpartum, and on resulting hypoplasia or stunting of the cerebellum. Rats in this study were exposed to MAM on 4 consecutive postnatal days (PND), beginning at one of six ages, from birth through weaning (PND 1, 5, 9, 13, 17, or 21). MAM was administered subcutaneously in doses of 3, 4, or 5 mg/kg twice per day. Rats were sacrificed at PNDs 28 or 84. The most sensitive age for MAM-induced stunting was determined to be PNDs 1-4. When 5 mg/kg MAM was administered twice daily on PNDs 1-4, body weight was reduced by 24% at age 28 days. Additionally, when compared to control rats, brains of the 28-day-old rats were stunted as follows: whole brain (11%), cerebellum (35%), hippocampus (11%), and olfactory bulb (27%). The effects of PND 1-4 MAM exposure were still evident at 84 days of age when cerebellum and olfactory bulbs from treated rats weighed 30% less than those same regions in control rats. These findings indicate that neonatal exposure to MAM results in permanent stunting in select regions of developing rat brain. This stunting, along with other known MAM effects, can be tailored by exposure age and dose to augment the use of MAM as a positive control for investigation of compounds with neurotoxic potential.

[1]  K. Kabat,et al.  Methylazoxymethanol as a developmental model of neurotoxicity. , 1985, Neurobehavioral toxicology and teratology.

[2]  D. Hillman,et al.  Ectopic glial cells in rat cerebella following neonatal administration of methylazoxymethanol acetate , 1988, Brain Research.

[3]  K. Ashwell Direct and indirect effects on the lateral geniculate nucleus neurons of prenatal exposure to methylazoxymethanol acetate. , 1987, Brain research.

[4]  D. Dahl,et al.  Astroglial development in microencephalic rat brain after fetal methylazoxymethanol treatment , 1986, International Journal of Developmental Neuroscience.

[5]  J. de Barry,et al.  Alteration of benzodiazepine receptors in mouse cerebellum following methylazoxymethanol treatment during development. , 1989, Brain research. Developmental brain research.

[6]  I. Hirono Carcinogenicity and neurotoxicity of cycasin with sepcial reference to species differences. , 1972, Federation proceedings.

[7]  D. Hillman,et al.  Selective ablation of neurons by methylazoxymethanol during pre- and postnatal brain development , 1986, Experimental Neurology.

[8]  J. de Barry,et al.  Immunohistochemistry with anti‐calbindin and anti‐neurofilament antibodies in the cerebellum of methylazoxymethanol‐treated mice , 1989, Journal of neuroscience research.

[9]  W. Balduini,et al.  Treatment with methylazoxymethanol at different gestational days: physical, reflex development and spontaneous activity in the offspring. , 1991, Neurotoxicology.

[10]  J. Altman,et al.  Post-Natal Origin of Microneurones in the Rat Brain , 1965, Nature.

[11]  I. Hirono,et al.  Induction of a Cerebellar Disorder with Cycasin in Newborn Mice and Hamsters∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[12]  J. Coyle,et al.  Effects of Fetal Methylazoxymethanol Acetate Lesion on the Synaptic Neurochemistry of the Adult Rat Striatum , 1981, Journal of neurochemistry.

[13]  L. Iversen,et al.  REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I , 1966, Journal of neurochemistry.

[14]  K. Lovell,et al.  Partial External Germinal Layer Regeneration in the Cerebellum Following Methylazoxymethanol Administration: Effects on Purkinje Cell Dendritic Spines , 1980, Journal of neuropathology and experimental neurology.

[15]  Masahiko Kato,et al.  Amino Acid Contents and Glutamate Decarboxylase Activity in Brain of Methylazoxymethanol-induced Microencephalic Rats , 1980 .

[16]  D. Hillman,et al.  Developmental factors related to abnormal cerebellar foliation induced by methylazoxymethanol acetate (MAM). , 1988, Brain research.

[17]  I. Hirono,et al.  Induction of a Neurological Disorder by Cycasin in Mice , 1967, Nature.

[18]  D. Hillman,et al.  Perinatal methylazoxymethanol acetate uncouples coincidence of orientation of cerebellar folia and parallel fibers , 1988, Neuroscience.

[19]  Alteration of mouse cerebellar circuits following methylazoxymethanol treatment during development: Immunohistochemistry of GABAergic elements and electron microscopic study , 1987, The Journal of comparative neurology.

[20]  J. Clos,et al.  Effects of methylazoxymethanol given at different stages of postnatal life on development of the rat brain. Comparison with those of thyroid deficiency. , 1977, Journal of neurobiology.

[21]  D. Woodward,et al.  Purkinje cell dendritic alterations after transient developmental injury of the external granular layer , 1975, Brain Research.

[22]  S. Griffin,et al.  CEREBELLAR DEVELOPMENT IN THE RAT AFTER EARLY POSTNATAL DAMAGE BY METHYLAZOXY‐METHANOL: DNA, RNA AND PROTEIN DURING RECOVERY , 1973, Journal of neurochemistry.

[23]  M. Shimada,et al.  Repair of the external granular layer of the hamster cerebellum after prenatal and postnatal administration of methylazoxymethanol. , 1970, Teratology.

[24]  J. Palacios,et al.  Autoradiographic localization of [3H]-l-glutamate binding sites in a model of cerebellar granule cell ectopia generated by methylazoxymethanol treatment , 1993, Journal of Chemical Neuroanatomy.

[25]  M. Paule,et al.  Behavioral effects of methylazoxymethanol-induced micrencephaly. , 1993, Behavioral neuroscience.

[26]  C. Vorhees,et al.  Pervasive hyperactivity and long-term learning impairments in rats with induced micrencephaly from prenatal exposure to methylazoxymethanol. , 1984, Brain research.

[27]  A. Hirano,et al.  Fine structure of cycasin-induced cerebellar alterations. , 1972, Federation proceedings.

[28]  Can He,et al.  Hyperactivity induced by prenatal administration of methylazoxymethanol: association with altered performance on conditioning tasks in rats. , 1984 .

[29]  M. Jones,et al.  PATHOGENESIS OF METHYLAZOXYMETHANOL‐INDUCED LESIONS IN THE POSTNATAL MOUSE CEREBELLUM , 1976, Journal of neuropathology and experimental neurology.

[30]  O. Mickelsen,et al.  Effects of methylazoxymethanol glucoside and methylazoxymethanol acetate on the cerebellum of the postnatal Swiss albino mouse. , 1972, Federation proceedings.

[31]  R. Douglas,et al.  The hippocampus and behavior. , 1967, Psychological bulletin.

[32]  O. Benešová,et al.  Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain , 1989, Neuropharmacology.

[33]  J. Coyle,et al.  Histological and neurochemical effects of fetal treatment with methylazoxymethanol on rat neocortex in adulthood , 1979, Brain Research.

[34]  J. Coyle,et al.  Methylazoxymethanol acetate ablation of mouse cerebellar granule cells: effects on synaptic neurochemistry. , 1982, Developmental neuroscience.

[35]  J Townsend,et al.  The brain in infantile autism , 1994, Neurology.

[36]  W. Webster,et al.  Vascularity and cytochrome oxidase distribution in the occipital cortex in MAM Ac-induced micrencephaly. , 1987, Brain research.